The final cancer drug thrown on the scrap heap... was an anti-human CCR8 antibody called Bay 3375968 or Lanerkitug.
Bayer had been assessing Lanerkitug as a monotherapy, and in combination with Merck's Blockbuster oncology med Keytruda... in a Phase1 study of patients with solid tumors. Again,...something to think about.